Put companies on watchlist
Drägerwerk AG & Co. KGaA
ISIN: DE0005550602
WKN: 555060
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Drägerwerk AG & Co. KGaA · ISIN: DE0005550602 · EQS - Company News (59 News)
Country: Germany · Primary market: Germany · EQS NID: 2049069
11 December 2024 02:06PM

Changes in the chair of the Dräger Supervisory Board


EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Personnel
Drägerwerk AG & Co. KGaA: Changes in the chair of the Dräger Supervisory Board

11.12.2024 / 14:06 CET/CEST
The issuer is solely responsible for the content of this announcement.


Changes in the chair of the Dräger Supervisory Board

Lübeck – Stefan Lauer, currently Chairman of all Dräger Supervisory Boards, has decided to step down as Chairman at the end of the year for health reasons. The Supervisory Board committees approved this move at their meetings today and passed the following resolutions:

From January 1, 2025, the chair of the Supervisory Board of Drägerwerk AG & Co. KGaA will be taken over by Maria Dietz, who has been a member of the Supervisory Board since 2018. The chair of all other committees (Joint Committee of Drägerwerk AG & Co. KGaA, Supervisory Board of Dräger Safety AG & Co. KGaA and Supervisory Board of Dräger Safety Verwaltungs AG) will be taken over by Professor Thorsten Grenz, who has been a member of all five Supervisory Boards since 2008 and remains Chairman of the Audit Committee. Stefan Lauer will remain Chairman of the Supervisory Board of Drägerwerk Verwaltungs AG.

Stefan Dräger, Chairman of the Executive Board of Drägerwerk Verwaltungs AG: “I am very pleased with this team effort by the Supervisory Board. In this way, we can ensure the Company's ability to act and enable the current Chairman to heal. I would like to thank Maria Dietz and Thorsten Grenz for their willingness to take on additional responsibility and wish Stefan Lauer good health.”

Once Stefan Lauer has made a full recovery, the committees will once again decide on their chair.



11.12.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck
Germany
Phone: +49 (0)451 882-0
Fax: +49 (0)451 882-2080
E-mail: info@draeger.com
Internet: www.draeger.com
ISIN: DE0005550602, DE0005550636 (Vorzugsaktien)
WKN: 555060, 555063 (Vorzugsaktien)
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Stuttgart, Tradegate Exchange
EQS News ID: 2049069

 
End of News EQS News Service

2049069  11.12.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2049069&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f
Visual performance / price development - Drägerwerk AG & Co. KGaA
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.